biotech
Bio-E-Gel Against Hot Flashes: Positive Phase III Clinical Trial Results
Filed in archive Drugs, Vaccines and Therapeutics by ruth on October 4, 2005
BlogPicture

The Phase III clinical trials on Bio-E-Gel revealed that three doses of Bio-E-Gel significantly decrease the number of hot flashes in menopausal women. The bio-identical estradiol gel also produced low estradiol blood levels, had a good safety profile, with minimal application site irritation, a side effect associated with transdermal patches.

Bio-E-Gel(TM) utilizes Antares Pharma's proprietary Advanced Transdermal Delivery gel system to deliver the hormone estradiol through the skin. Antares Pharma has licensed its estradiol gel in its patented ATD� system to BioSante for North America, but retains all rights to develop, market and license its own estradiol ATD� gel products in Europe, Japan and other important markets.

Read more about the clinical trial here.

Permalink: Bio-E-Gel Against Hot Flashes: Positive Phase III Clinical Trial Results
Tags: menopause  hormone  biotech  clinical  phase  phase+clinical  clinical+trial  trial+results 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/9926
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Bio-E-Gel Against Hot Flashes: Positive Phase III Clinical Trial Results:

  • Currently 6.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.00 out of 2 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!